Division of Pediatric Drug Development

First Page		Document Content
Date: 2005-11-17 15:21:47 Pharmacology Sumatriptan GlaxoSmithKline Food and Drug Administration Nasal spray Triptans Medicine Pharmaceutical sciences		Division of Pediatric Drug Development Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 28,09 KB Share Document on Facebook

	Health Canada Endorsed Important Safety Information on ® MIACALCIN Nasal Spray SANDOZ CALCITONIN Nasal Spray APO-CALCITONIN Nasal Spray DocID: 1uWea - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NARCAN NASAL SPRAY safely and effectively. See full prescribing information for NARCAN® NASAL SPRAY. NARCAN® (nalo DocID: 1u48P - View Document
	~ Research Spotlight ~ Penn Dental Medicine Researchers Study Safety of Nasal Spray to Numb Teeth Surveys indicate that up to 40 million people in the U.S. may avoid going DocID: 1rwI7 - View Document
	Pressureze “Pressureze® Nasal Mist”, first rolled out in mid 2011 and was the first Non-GMO Verified nasal spray on the market. Jimbo’s…Naturally! was the first retail store to receive product. A San Diego base DocID: 1rhbO - View Document
	NARCAN® (Naloxone Hydrochloride) NASAL SPRAY Now Available in the United States for Emergency Treatment of Known or Suspected Opioid Overdose First and Only FDA-Approved Nasal Spray Form of Naloxone Dublin, Ireland – DocID: 1qEuy - View Document